John Wayne Cancer Institute and Singapore’s Clearbridge BioMedics to establish a circulating tumor cell center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE JOHN WAYNE CANCER INSTITUTE at the St. Johns Health Center, Providence Health Systems in Santa Monica, CA, and Singapore-based Clearbridge BioMedics will work together to establish a Circulating Tumor Cell Center of Research Excellence. This new center builds upon JWCI’s experience in CTC assessment in patients and Clearbridge BioMedics’ expertise in isolating CTCs. The...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login